drug
azelaic acid
Marketedupdated 3mo agoby Almirall SA
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3all catalysts(0)
nothing on the calendar yet
Trials studying azelaic acid
- phase1To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel
- phase3Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne
- phase2A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis
- phase3Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
- phase1Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea
- phase2A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face
- phase4A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 18, 2027
~1.1 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Feb 28, 2029method-of-use (U-1796)US 92112592.5y
- Dec 8, 2027formulationUS 92657251.3y
- Oct 18, 2027formulationUS 101178121.2y
- Sep 18, 2027formulationUS 77000761.1y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed just now
Found something off?
comments(0)
5-min edit window · permanent after that